格隆汇1月12日丨生物制药商Immuron(IMRN.US)盘前涨12.21%报2.94美元。公司已获得美国国防部为该公司旗下Travelan药品提供的资助,这一举措是为了研究口服免疫疗法的给药方案,以供美国军队使用。Immuron是一家处于临床阶段的医疗公司,专注于一种新型特异性... 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-021766 Act: 34 Size: 53 KB 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-020464 Act: 34 Size: 46 KB 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-012684 Act: 34 Size: 50 KB 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-009324 Act: 34 Size: 1 MB 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-002232 Act: 34 Size: 52 KB 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-001803 Act: 34 Size: 43 KB 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-001636 Act: 34 Size: 81 KB 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-065576 Act: 34 Size: 2 MB 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-065574 Act: 34 Size: 62 KB 网页链接
$Immuron(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-059740 Act: 34 Size: 1 MB 网页链接